APNHY Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 16:37):

Stats
Šios dienos apimtis	109.00
Vidutinė apimtis	190.00
Rinkos kapitalizacija	5.55B
Last Dividend	$0.184 ( 2023-09-21 )
Next Dividend	$0 ( N/A )
P/E	21.53
ATR14	$0 (0.00%)

Aspen Pharmacare Holdings Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Aspen Pharmacare Holdings Finansinės ataskaitos

Annual	2023
Pajamos:	$2.29B
Bruto pelnas:	$1.02B (44.59 %)
EPS:	$0.660

FY	2023
Pajamos:	$2.29B
Bruto pelnas:	$1.02B (44.59 %)
EPS:	$0.660

FY	2022
Pajamos:	$2.54B
Bruto pelnas:	$1.15B (45.40 %)
EPS:	$0.940

FY	2021
Pajamos:	$37.77B
Bruto pelnas:	$17.76B (47.03 %)
EPS:	$10.53

Financial Reports:

No articles found.

Aspen Pharmacare Holdings Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.133 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0.184 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Aspen Pharmacare Holdings Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.17 - Stable (3.39%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.101	2010-10-06
Last Dividend	$0.184	2023-09-21
Next Dividend	$0	N/A
Payout Date	2023-10-11
Next Payout Date	N/A
# dividends	12	--
Total Paid Out	$2.03	--
Avg. Dividend % Per Year	0.00%	--
Score	2.69	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.17
Div. Directional Score	7.90	--

Next Divdend (Est)
(2024-08-07)

$0.190 Estimate 3.02 %

Dividend Stability

0.24 Very Poor

Dividend Score

2.69

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SRCU	Ex Dividend Knight	2023-08-14	Quarterly	0.00%
HCBN	Ex Dividend Knight	2023-10-03	Quarterly	0.00%
AILLO	Ex Dividend Knight	2023-07-14	Semi-Annually	0.00%
NTOIY	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
CRZBY	Ex Dividend Junior	2023-06-01	Sporadic	0.00%
TMSNY	Ex Dividend Junior	2023-05-05	Annually	0.00%
IFJPY	Ex Dividend Junior	2023-08-10	Annually	0.00%
AVHNY	Ex Dividend Junior	2023-05-26	Annually	0.00%
PRNDY	Ex Dividend Knight	2023-06-30	Semi-Annually	0.00%
EBGEF	Ex Dividend Knight	2023-08-14	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.114	1.500	7.72	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0349	1.200	8.84	10.00	[0 - 0.3]
returnOnEquityTTM	0.0743	1.500	-0.285	-0.428	[0.1 - 1]
payoutRatioTTM	0.315	-1.000	6.85	-6.85	[0 - 1]
currentRatioTTM	1.918	0.800	5.41	4.33	[1 - 3]
quickRatioTTM	1.053	0.800	8.51	6.81	[0.8 - 2.5]
cashRatioTTM	0.505	1.500	8.30	10.00	[0.2 - 2]
debtRatioTTM	0.259	-1.500	5.68	-8.52	[0 - 0.6]
interestCoverageTTM	88.18	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	14.11	2.00	5.30	10.00	[0 - 30]
freeCashFlowPerShareTTM	7.62	2.00	6.19	10.00	[0 - 20]
debtEquityRatioTTM	0.422	-1.500	8.31	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.450	1.000	5.83	5.83	[0.2 - 0.8]
operatingProfitMarginTTM	0.200	1.000	8.00	8.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.174	1.000	-0.146	-0.146	[0.2 - 2]
assetTurnoverTTM	0.307	0.800	-1.290	-1.032	[0.5 - 2]
Total Score				10.62

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	21.09	1.000	7.97	0	[1 - 100]
returnOnEquityTTM	0.0743	2.50	-0.183	-0.428	[0.1 - 1.5]
freeCashFlowPerShareTTM	7.62	2.00	7.46	10.00	[0 - 30]
dividendYielPercentageTTM	0.00419	1.500	9.90	0	[0 - 0.4]
operatingCashFlowPerShareTTM	14.11	2.00	5.30	10.00	[0 - 30]
payoutRatioTTM	0.315	1.500	6.85	-6.85	[0 - 1]
pegRatioTTM	0.0356	1.500	-3.10	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.147	1.000	8.83	0	[0.1 - 0.5]
Total Score				5.17

Aspen Pharmacare Holdings

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.